1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. THARIMMUNE INC
Tharimmune Inc XNAS: THAR
4.77 -0.43 (-8.27%)
839.2K
XNAS Volume

XNAS 03 Sep, 2025 11:39 AM (EDT)



Insider Trading disclosures for Tharimmune Inc

The latest disclosure was made by Sanam Parikh in Tharimmune Inc where a trade of 50,000 Stock Option done was reported to US exchanges on Aug. 4, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sanam Parikh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2025 50,000 50,000 - - Stock Option
Sireesh Appajosyula Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2025 90,000 205,962 - - Stock Option
Kelly J. Anderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2025 6,300 6,300 - 0 Common Stock
Sanam Parikh Director Purchase of securities on an exchange or from another person at price $ 1.45 per share. 20 Jun 2025 1,000 1,770 - 1.5 1,450 Common Stock
Sireesh Appajosyula Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.42 per share. 20 Jun 2025 690 64,868 - 1.4 980 Common Stock
Sireesh Appajosyula Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.48 per share. 20 Jun 2025 60,806 64,178 - 1.5 89,993 Common Stock
Sanam Parikh Director Purchase of securities on an exchange or from another person at price $ 1.30 per share. 15 May 2025 770 770 - 1.3 1,001 Common Stock
Sireesh Appajosyula Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2025 52,875 115,962 - - Options (right to buy)
Randy Milby Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2025 80,958 138,665 - - Options (right to buy)
Randy Milby Director, CEO 19 Dec 2024 4,600 17,534 - 2.1 9,752 Common Stock
Sireesh Appajosyula Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 2.02 per share. 13 Nov 2024 5,000 10,758 - 2.0 10,096 Common Stock
Randy Milby Director, CEO 08 Oct 2024 646 12,580 - 2.1 1,350 Common Stock
Randy Milby Director, CEO 08 Oct 2024 354 12,934 - 2.1 743 Common Stock
Randy Milby Director, CEO 08 Oct 2024 1,500 11,934 - 2.1 3,128 Common Stock
Sireesh Appajosyula Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 1.93 per share. 08 Oct 2024 5,000 5,758 - 1.9 9,650 Common Stock
Leonard L. Mazur Director 09 Aug 2024 2,353 27,353 - - Options (right to buy)
Sireesh Appajosyula Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 1.93 per share. 09 Aug 2024 5,000 16,364 - 1.9 9,650 Common Stock
Sireesh Appajosyula Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 38,087 63,087 - - Options (right to buy)
Lynne A. Bui Director 09 Aug 2024 2,353 27,353 - - Options (right to buy)
Kelly J. Anderson Director 09 Aug 2024 2,353 52,353 - - Options (right to buy)
Randy Milby Director, CEO 09 Aug 2024 57,707 57,707 - - Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures